INTRODUCTION
Studies of the functions of the actin cytoskeleton in budding yeast (Saccharomyces cerevisiae) have pointed to roles in polarized growth and protein secretion. Mutants defective in the structural gene encoding yeast actin (actl mutants) display characteristic defects in cell morphology, in the kinetics of protein secretion, and accumulate intracellular membranous structures, including vesicles (reviewed in Welch et al., 1994; Botstein et al., 1997) .
The organization of the actin cytoskeleton, as observed by immunofluorescence and immunoelectron microscopy (immuno-EM), is entirely consonant with this view of actin function. The yeast actin cytoskeleton consists of two major structures, cables and cortical patches (Adams and Pringle, 1984; Kilmartin and Adams, 1984; Novick and Botstein, 1985; Read et al., t Corresponding author. 1992; Mulholland et al., 1994) . These structures are asymmetrically organized along the axis of cell growth throughout the cell cycle. Cortical actin patches are concentrated in areas of active cell surface growth within the bud for most of the cell cycle and at the septum during cytokinesis. Actin cables are localized within both the mother and bud and are oriented along the mother-daughter cell axis.
The actin cytoskeleton contains proteins other than actin itself. Many of these proteins have been identified, some by genetic methods, some by biochemical methods, some by homologies to proteins known to bind actin in other organisms, and some by use of the two-hybrid system for detecting protein interactions (reviewed in Botstein et al., 1997) . The phenotypes of mutants defective in the genes specifying these actinassociated proteins tend to be similar to at least some aspects of the actl mutant phenotypes, particularly with respect to loss of cell polarity. Surprisingly, deletion of the gene encoding the actin-binding protein ABP1 does not produce a detectable phenotype (Drubin et al., 1988) . However, null mutations in this gene show synthetic lethality with null mutations in another gene (SAC6) encoding an actin binding protein related to fimbrin (Adams et al., , 1991 . Genetic screening for mutations in other genes that display synthetic lethality with abpl mutations, resulted in the recovery of two new genes, SLAl and SLA2 (Holtzman et al., 1993) . Although neither of these genes is essential, deletion of either gene produces defects in the organization of the actin cytoskeleton and in cell polarity (Holtzman et al., 1993) .
Secretion-defective mutations, especially those affecting the transit of proteins from the Golgi to the plasma membrane (e.g., sec4, secl, or sec6), often show accumulation of a uniform class of large vesicles (Novick et al., 1980 . In wild-type cells, these vesicles contain on their cytoplasmic surface Sec4p, a small GTPase of the Ras family that is involved mediating vesicle fusion to the plasma membrane (Salminen and Novick, 1987; Goud et al., 1988; Walworth et al., 1992) . Such vesicles are seen in wild-type cells only in very small buds, near the septum at cytokinesis, and in shmoo tips-all sites of active membrane growth. Actin mutants and many of the actin cytoskeleton mutants also accumulate apparently similar large vesicles. Further, actin mutants have defects in protein secretion analogous to those manifested by the lateacting secretory mutants. Together with the polarized organization of the actin cytoskeleton, these observations implicated actin in the vectorial transport of late secretory vesicles to the plasma membrane.
The argument for actin's involvement in membrane traffic has been buttressed further by the finding that some actl mutants and sac6 null mutants (but not abpl null mutants) are defective in receptor-mediated endocytosis (Kubler and Riezman, 1993) . Phenotypic screening for endocytosis mutants identified END4, a gene required for both receptor-mediated and fluidphase endocytosis (Raths et al., 1993; Munn et al., 1995) . Upon DNA sequencing, SLA2 and END4 turned out to be the same gene. This same gene was found in a third genetic screen for enhancers of the mutant phenotype of mutations in the PMA1 gene, which encodes the yeast plasma membrane proton ATPase (Na et al., 1995) .
To clarify the connection between the actin cytoskeleton and membrane trafficking in yeast, we have characterized the defects manifested by sla2 and actl mutants by using both immuno-EM and biochemical analysis. In the course of this study, we have found a new class of large secretory vesicle containing Yptlp in place of Sec4p. These Yptlp-associated vesicles accumulate when the actin cytoskeleton is perturbed.
MATERIALS AND METHODS Yeast Strains and Growth Conditions
The yeast strains used in this study are listed in Table 1 ; all strains listed are direct descendants of strain S288C. Standard genetic techniques including growth, crosses, sporulation, tetrad analysis, and complementation tests were done as described in Guthrie and Fink (1991) and Kaiser et al. (1994) .
For metabolic labeling experiments yeast strains were grown in SDYE [0.67% yeast nitrogen base (Difco, Detroit, MI), 0.2% Bacto yeast extract (Life Technologies, Paisley, Scotland)], 2% glucose supplemented with 20 mg/ml adenine, 20 mg/ml histidine, 20 mg/ml uracil, 20 mg/ml tryptophan, 20 mg/ml lysine, 20 mg/ml leucine, and 20 mg/ml tyrosine (E. Merck, Darmstadt, Germany). YNB is SDYE without yeast extract.
For immuno-EM, strains were grown at either the permissive temperature 25°C or grown at 25°C and then shifted to the restrictive temperature 37'C in yeast-extract peptone medium (YEP; Sherman et al., 1986) For immunoisolation of CPY, cells were spun down in a microcentrifuge and the supernatant was discarded. Cells were resuspended in 0.44 ml of phosphate-buffered saline (PBS: 0.1 M NaCl, 80 mM Na2HPO4, 20 mM NaH2PO4) and 1% SDS containing protease inhibitor mixture (antipain, leupeptin, pepstatin, each at a final concentration of 1 ,ug/ml, phenylmethylsulfonyl fluoride at 1 mM final concentration) and 0.2 g of acid-washed glass beads were added. Samples were vortexed four times consecutively at maximum setting for 1 min with an incubation on ice between each. Samples were boiled for 5 min and supernatants were then transferred to a fresh Eppendorf tube. Glass beads, washed with 1.32 ml of PBS and 1.33% Triton X-100 (TX-100) were added to the lysate. Particulate material was removed by centrifugation for 10 min at 13,000 rpm in a microcentrifuge and supernatants were transferred to new tubes. Rabbit anti-CPY polyclonal antibodies (Schimmoller et al., 1995) were added and incubated for 90 min at room temperature (RT). Then, 50 ,ul of 30% protein A-Sepharose in PBS were added and incubation was continued for another 60 min at RT. The protein A-Sepharose beads were then recovered by centrifugation and transferred in 0.5 ml of PBS and 1% TX-100 to new tubes. Beads were washed twice in the same buffer, transferred in 10 mM TrisHCl (pH 7.5), and 10 mM NaCl to new tubes, and finally resuspended in 60 ,lI of 2x sample buffer [4% SDS, 4% 2-mercaptoethanol, 20% glycerol, 125 mM Tris-HCl, pH 6.8, 0.02% bromophenol blue]. Samples were subsequently boiled for 5 min, beads were spun down, and 45 ,ul of the supematant were loaded onto SDS-7.5% polyacrylamide gels to separate immunoprecipitated proteins. Gels were fixed in 30% ethanol and 10% acetic acid, dried onto Whatman paper, and exposed to XAR X-ray films (Kodak, Rochester, NY).
Maturation of Gaslp was followed similarly by using the same immunoprecipitation protocol except that rabbit anti-Gaslp polyclonal antibodies (Schimmoller et al., 1995) were used. Gels were exposed to Storage Phosphor Screen (Molecular Dynamics, Sunnyvale, CA) and visualized with the Image Quant V3.2 software (Molecular Dynamics).
To follow maturation and secretion of invertase, cells were grown in SDYE at 24°C and then converted to spheroplasts in buffer containing 0.1% glucose, essentially as described in Schimmoller et al. (1993) . Spheroplasts were harvested by centrifugation at 1500 rpm in a GLC centrifuge; washed twice in 10 ml of YNB, 0.1% glucose, and 0.8 M sorbitol; and resuspended to a concentration of 108 cells/ml in YNB, 0.1% glucose, and 0.8 M sorbitol. The spheroplasts were then transferred to 50-ml Falcon tubes and preincubated at either 24°C or 37°C for 15 min in a rotary water shaker. Proteinlabel mixture was subsequently added as described above and spheroplasts were incubated for 4 more min. The chase was initiated as described above and 0.4 ml of culture medium was removed at 0, 5, 15, and 30 min after initiating the chase and transferred into Eppendorf tubes on ice containing NaF and NaN3 at a final concentration of 25 mM. Cells were spun down; supematants were transferred to new tubes. To the transferred supematant fractions, 44 Al of 10% SDS were added while the cell fractions were resuspended in 440 ,ul of PBS and 1% SDS. All samples were boiled for 5 min and then spun for 10 min at 13,000 rpm in a microcentrifuge to remove all remaining particulate material. Supernatants were transferred to new tubes and 1.32 ml of PBS and 1.33% TX-100 was added to all samples. Anti-invertase polyclonal rabbit antibodies (Schimmoller et al., 1995) were then added and samples were processed as described above.
Fixation and Processing for Immuno-EM Fixation and processing of yeast cells was done as described in Mulholland et al. (1994) except for the following change in fixation conditions. The buffered fixative used in this study was 40 mM potassium phosphate, pH 6.7, 0.8 M sorbitol, and 4% formaldehyde freshly prepared from paraformaldehyde (Polysciences, Warrington, PA), 0.4% glutaraldehyde (EM grade, Polysciences), 1 mM MgCl2, and 1 mM EGTA. This fixative has a lower osmotic strength than our standard fixative. Use of a lower osmotic strength fixative was necessary because fixation at our standard osmotic strength (provided by 1 M sorbitol) produced plasmolysis in the actl mutants. This was particularly noticeable in mutant cells grown at 370C.
Ultramicrotomy, Immunolabeling, and Electron Microscopy
Thin sections measuring 60-70 nm (as determined by a gray/silver interference color) were cut with a 350 diamond knife (Diatome, Fort Washington, PA) and were picked up on 300-mesh nickel grids (Polysciences) that had been made sticky with a dilute Formvar solution (Wright and Rine, 1989) .
Production, purification, and characterization of affinity-purified polyclonal rabbit antibodies raised against TrpE-Yptlp and TrpESec4p fusion proteins have been described previously (Goud et al., 1988; Segev et al., 1988) . The specificity of the rabbit anti-a-1,6-mannose antisera preparation has been previously demonstrated (Franzusoff and Schekman, 1989; Preuss et al., 1992) . Antibody incubations were performed as described previously (Mulholland, et al., 1994) . All antibodies were diluted in PBST (140 mM NaCl, 3 mM KCI, 8 mM Na2HPO4, 1.5 mM KH2PO4, 0.05% Tween 20) containing 0.5% bovine serum albumin and 0.5% ovalbumin (Sigma, St. Louis, MO) and were incubated with cell sections mounted on grids as described above. Anti-Yptlp antibodies were diluted 1:30, antiSec4p antibodies were diluted 1:30, and anti-a-1,6-mannose antisera was diluted 1:80,000. The 10-nm-gold-conjugated anti-rabbit IgG (goat) secondary antibodies (BioCell, Cardiff, United Kingdom) were all diluted 1:50 in PBST, 0.5% bovine serum albumin, and 0.5% ovalbumin. In the absence of the primary antibody the anti-rabbit secondary antibodies did not react with the cell sections.
Following immunolocalization, cell sections were postfixed in 8% glutaraldehyde (EM grade, Polysciences) and stained with uranyl acetate and lead citrate as previously described (Mulholland et al., 1994) . All observations were made on a Phillips 300 EM at an accelerating voltage of 80 kV using a 20-,um-diameter objective aperture.
ac-Factor Treatment of Wild-Type and sla2 Cells Wild-type (RH448) and sla2-41 (RH1597) cell cultures were grown at 25'C in YPD (2%) medium to an OD6w of approximately 0.3 and then a-factor (Sigma, St. Louis, MO) was added to a concentration of 2.5 ,uM (Sprague, 1991) . Immediately after the addition of a-factor, the cultures were split and one half of each culture remained at 25°C and the other half was incubated at 37°C. Samples were then taken from both cultures at 0, 15, 30, 60, and 90 min following the addition of a-factor and immediately fixed and processed for immuno-EM as described above.
G, arrest and shmooing (formation of a pear-shaped cell morphology) was monitored with phase-contrast light microscopy. The degree of shmoo formation in wild-type and sla2 mutant cultures was quantitatively similar at 37°C, at all time points observed. After 1.5 h at 37°C, approximately 50% of all cells observed in both the wild-type and mutant cell cultures had formed shmoos. Cell sections from the 60-min time point were used in the immuno-EM experiments described.
Phalloidin Staining of the Actin Cytoskeleton
Wild-type and sec4-8 cells, growing at 25°C or incubated at 36°C for 30 and 60 min, were fixed by direct addition of an equal volume of methanol-free 10% formaldehyde (Polysciences). After an initial 10-min fixation at culture temperature (25°C or 36°C), cells were collected by centrifugation and resuspended in 4% formaldehyde and incubated at RT for 1 h. Cells were then washed three times in PBS and resuspended in 0.5 ml of PBS. Subsequent processing for rhodamine-phalloidin fluorescence light microscopy was according to Pringle et al. (1989) .
RESULTS sla2 Mutants Exhibit Defects in Wall Deposition
To determine whether sla2 mutants exhibited any ultrastructural phenotypes indicative of defects in secretion and cell surface growth, cultures of the deletion strains sla2A1 and sla2A2 and the point mutation strains sla2-5 and sla2-41 were fixed, sectioned, stained, and examined in the electron microscope. This examination of the sla2 mutants revealed a characteristic aberrant cell wall morphology. About half of all mutant mother cells observed had cell walls that were thicker than the wild-type cell wall and these thicker walls often appeared to consist of several distinct layers, each with a thickness about that of a normal cell wall ( Figure 1 ).
In contrast, all growing buds, including large buds that had finished septation but were still attached to their mother cells exhibited wild-type wall morphology. In all budded cells observed, the inner plasma membrane-associated wall on the mother cell was continuous with the new wall of the bud. Often, the outer wall(s) of the mother cell appeared to have been torn open at the site of bud emergence ( Figure 1 , B and C).
Similar defects in wall ultrastructure were observed in cells from both the sla2 deletion and point mutation strains.
Consistent with defects in cell wall deposition, defects in septum morphology also were observed in the sla2 mutants. Examination of mutant cells undergoing cytokinesis often revealed inclusions of cytoplasm within the septum wall ( Figure 1D ). These wall and septum abnormalities were observed to the same extent at both the permissive and nonpermissive temperatures, indicating a constitutive temperature-independent defect.
Examination of actl-l mutant cells at both permissive (25°C) and restrictive (37°C) temperature revealed aberrant morphology of the cell wall and septum (Figure 1, E and F). These defects were identical to those observed in the sla2 mutants. (Novick et al., 1980 (Salminen and Novick, 1987; Goud et al., 1988; Walworth et al., 1992) . Furthermore, Sec4p has been shown to be associated with late secretory vesicles purified from several different late sec mutants (Goud et al., 1988 sibly Golgi-derived transport vesicles. In yeast, outer chain glycosylation of secreted proteins is initiated in an early (cis-Golgi) compartment with the addition of a-1,6-mannose residues (Esmon et al., 1981; Ballou, 1982; Franzusoff and Schekman, 1989; Graham and Emr, 1991) . Therefore, a-1,6-mannose modification can be used as a marker for secreted proteins that have passed through this Golgi compartment (Preuss et al., 1992) .
To see whether the vesicles that accumulated in the sla2 cells contained a-1,6-mannose-modified cargo and were thus Golgi-derived, we conducted immuno-EM experiments using antiserum directed against a-1,6-mannose (Figure 3) . When examined by immuno-EM, most of the large, 40-to 60-nm, vesicles that accumulated in sla2 mutants displayed some localization of the antiserum directed against a-1,6-mannose. The clusters of vesicles ( Figure 3A ) and the ring-like membrane structures that were occasionally observed (10% of cell sections) in the sla2 deletion strains at nonpermissive temperature labeled consistently and often heavily with the anti-a-1,6-mannose antiserum ( Figure 3B) . No anti-a-1,6-mannose labeling was observed on the nuclear or peripheral ER in either mutant or wild-type cell sections. These results suggest that the vesicles that accumulate in these mutants are, in fact, Golgi-derived. Yptlp, like Sec4p, is a small GTPase; the sequences of the two proteins are highly homologous and their function is largely preserved in chimeras made between them (Schmitt et al., 1986; Segev and Botstein, 1987; Schmitt et al., 1988; Segev et al., 1988; Dunn et al., 1993) . However, unlike Sec4p, Yptlp is required for vesicular transport early in the secretory pathway, between the ER and the Golgi (Segev et al., 1988; Bacon et al., 1989) . More recently, Yptlp has been shown to be required for intra-Golgi protein transport (Jedd et al., 1995) . Previously we had shown that Yptlp is associated with membrane compartments to which known yeast Golgi proteins also are located (Pruess et al., 1992) . Therefore, to determine whether the vesicles in the sla2 mutants were accumulating at a Yptlpassociated transport step, we conducted immuno-EM experiments using affinity-purified antibodies directed against Yptlp.
Anti-Yptlp antibodies applied to sla2 cell sections, taken from samples grown either at 25°C or incubated at 37°C, did indeed label the large, 40-to 60-nm, vesicles that accumulated within medium-and largesized buds (Figure 4 ). Labeling for Yptlp was strongest on the vesicles clustered at the base of the neck of small buds as well as clusters located within larger sized buds (Figure 4 , A, C, and E). Importantly, there was no localization of the anti-Yptlp antibodies to the 40-to 60-nm vesicles that filled the early small bud that, it will be recalled, labeled abundantly on wildtype cells sections, with antibodies to Sec4p (see Figure 2, A and B; Figure 4C ). Additionally, Yptlp antibodies also stained vesicles associated with the ring-like membrane structures ( Figure 4F ) observed in the deletion strains incubated at 37°C. Notably, antiYptlp antibodies applied to wild-type cell sections localized 40-to 60-nm vesicles that often appeared to be clustered ( Figure 5, A and B) . However, these Cross et al., 1988) . The apex of this cell is called the shmoo tip and many components of the yeast cell become polarized toward the shmoo tip in a manner similar to that observed in small budded cells (for recent reviews, see Chant, 1996; Drubin and Nelson, 1996) . Polarization of secretory components, particularly Golgi membranes and late secretory vesicles, in a-factor-exposed G1-arrested cells and in non-a-factor-exposed small budded cells appears to be analogous (Baba et al., 1989; Preuss et al., 1992) . The vesicles that accumulate at the shmoo tip, like those that accumulate in the small bud, were therefore presumed to be Sec4p-containing vesicles. Thus, by exposing Mata cells to a-factor, it is possible to obtain a large population of cells that mimic the small budded stage of the cell cycle. We used this technique to investigate the characteristic positioning of clustered Yptlp-positive vesicles at the base of the neck of small budded sla2 cells and to see if Sec4p-positive vesicles appear near the shmoo tip.
sla2-41 cells were concurrently exposed to a-factor (2.5 ,uM) and shifted to 37°C for 1 h and then prepared for immuno-EM. Shmooed sla2-41 cells revealed a consistent positioning of a cluster of large vesicles at the base of the shmoo tip and an accumulation of similarly sized vesicles within the shmoo tip. We observed strong localization of the anti-Yptlp antibodies to the clustered vesicles located at the base of the shmoo ( Figure 5C ) and no localization to the vesicles located at the shmoo tip. In contrast, the vesicles located at the shmoo tip were immunoreactive with anti-Sec4p antibodies, but the clustered vesicles were not ( Figure 5D ).
These results suggest strongly that the location of clustered, Yptlp-containing vesicles at the base of the neck of small budded sla2 cells is a spatially and temporally specific event analogous to the positioning of the wild-type Golgi compartment at the base of the neck of small budded cells. Most importantly, the localization of anti-Sec4p antibodies to the vesicles accumulated at the shmoo tip shows that in the sla2 (Novick et al., 1980; Kaiser and Schekman, 1990 ). The secl7-1 secretory mutant disrupts ER-to-Golgi transport and accumulates small, 20-to 30-nm (using our methods), vesicles (Figure 6 , A and B; see Novick et al., 1980; Kaiser and Schekman, 1990 ). Double-mutant haploid strains containing the sla2-5 allele in pair-wise combination with the secl2-4 and secl7-1 secretion mutants were conMolecular Biology of the Cell Secretory Defects in sla2 Mutants structed and confirmed by using complementation analysis (see MATERIALS AND METHODS).
Double mutants grown at 25°C contained large, 40-to 60-nm, vesicles and were morphologically similar to the sla2 mutants grown at 25°C. However, when incubated at 37°C the double mutants accumulated secretory structures characteristic of the secretory mutant's defect. The sla2-5 secl2-4 double mutants, at 37°C, accumulated ER membranes and the sla2-5 secl7-1 double mutants accumulated small, 20-to 30-nm, vesicles; the latter are shown in Figure 6 , C and D. These results demonstrate that vesicle accumulation in the sla2 mutants is dependent upon the SEC17-mediated ER-to-Golgi transport step of the secretory pathway.
It should be noted that the double wall phenotype of the sla2 mutants was observed in the secl2-4 sla2-5 and the seci7-1 sla2-5 double mutants grown at 25°C or incubated at 37°C but not in the sec mutants alone (compare Figure 6 , A and B to C and D).
sla2 Mutants Are Partially Defective in the Secretion of Hyperglycosylated Invertase
The accumulation of large vesicles in the sla2 mutants suggested a possible defect in protein secretion similar to that observed in actin mutants. Previous biochemical analysis of the actl-1 allele demonstrated defects in the secretion of fully glycosylated invertase, suggesting a partial block in Golgi-to-plasma membrane transport (Novick and Botstein, 1985) . However, localization of Yptlp antibodies to the vesicles that accumulate in the sla2 actin cytoskeleton mutants suggested to us a defect in intra-Golgi transport. To test this and to determine more specifically where in the secretory pathway sla2 mutants are defective, we undertook a biochemical analysis of protein secretion in the sla2 mutants. To assess protein traffic through different stages of the secretory pathway, we followed the transport and maturation of three different marker proteins, carboxypeptidase Y (CPY), a glycophospholipid-anchored surface protein (Gaslp), and invertase. Each of these proteins undergoes compartment-specific N-linked glycosylation modification and/or proteolytic processing, and each can be exploited to measure transport rates through different stages of the secretory pathway (Schimmoller et al., 1995) .
We first investigated the integrity of the vacuole biogenesis pathway, which uses the ER and Golgi portions of the secretory pathway, by following the maturation of CPY. Upon arrival at and subsequent transport through the Golgi compartment, the ER precursor plCPY is converted to the fully glycosylated protein p2CPY, which is then transported from a late Golgi compartment to the vacuole. Arrival of p2CPY in the vacuole is accompanied by proteolytic processing of the protein to its fully active mature mutants (sla2-5 and sla2Al) were grown at 24°C, and shifted to 37°C for 15 min prior to initiating a pulsechase experiment. Cells were harvested at 0, 5, 15, and 30 min after the pulse and CPY was immunoprecipitated from total cell lysates. As shown in Figure 7 , CPY matures with wild-type kinetics in both sla2-5 and sla2Al mutants. This result indicates that protein traffic from the ER to the Golgi as well as through the late Golgi compartment to the vacuole is normal in the absence of SLA2 function. Because transport from the ER to the Golgi compartment is differentially regulated for some cargo molecules (Schimmoller et al., 1995) , we also followed the maturation kinetics of the GPI-anchored protein Gaslp. Gaslp undergoes N-linked core glycosylation in the ER and outer-chain glycosylation upon arrival in the Golgi compartment. Wild-type and mutant (sla2A2) cells were grown at 24°C and incubated at 24°C or 37°C for 15 min prior to initiating a pulsechase experiment. Cells were harvested at different time points between 0 and 60 min after an initial 4-min pulse and then Gaslp was immunoprecipitated from total cell lysates. As shown in Figure 8 , Gaslp acquired Golgi-specific modifications in the sla2 deletion mutant with kinetics identical to that observed in wild-type cells. This is further evidence that transport from the ER to the Golgi apparatus is not impaired in the absence of SLA2 function.
The soluble periplasmic enzyme invertase was used to assess protein transport from the Golgi compartment to the plasma membrane. Upon transport from the ER to the Golgi compartment, invertase is converted from its core-glycosylated form to a hyperglycosylated Golgi form, which is subsequently secreted into the periplasmic space. Wild-type (SLA2) and mutant (sla2-5, sla2Al) cells were grown at 24°C, converted to spheroplasts, and then shifted to low-glucose medium to induce invertase expression. Before initiating the pulse-chase protocol, cells were preincubated for 15 min either at 24°C or 37°C. After a 4-min pulse, cells were harvested at 0, 5, 15, and 30 min and centrifuged to separate internal (nonsecreted) from external (secreted) invertase. Invertase from these two fractions was then recovered by immunoprecipitation.
As can be seen in Figure 9 , there is a minimal defect in invertase secretion in the sla2 mutants at their permissive growth temperature. In contrast, at 37°C, a significant amount of invertase accumulated inside the sla2-5 and sla2A1 mutants. Significantly, this internal A SLA2
invertase is hyperglycosylated, consistent with the previous observations indicating that intra-Golgi transport is not perturbed in the sla2 mutants. Independent experiments showed that the secretion defect exhibited by the sla2 mutants is not due to differences in the extent of sheroplast formation at 24°C and at 37°C (Wesp and Riezman, unpublished observations). Taken together these results suggest that the sla2 mutants, as previously shown for the actl-1 mutant, are partially defective in the late Golgi-to-plasma membrane steps of protein secretion.
Immuno-EM Characterization of an Actin Mutant, actl-l As we have shown, sla2 mutants accumulate vesicles and exhibit secretory defects similar to those previously observed in actin mutants. We therefore wished to confirm that the sla2 mutants were accumulating the same class of secretory vesicles that accumulates in the actin mutants. To this end, we conducted immuno-EM experiments on the actl-l mutant using sla2-5 Like the sla2 mutants, actl-l exhibited a polarized accumulation of large, 40-to 60-nm, vesicles at 25°C and at 37°C. However, in contrast to the sla2 mutants, vesicle accumulation in the actl-1, after 1 h at 37°C, was not as strongly polarized into the bud. Figure 10 shows that the vesicles that accumulated in the actin mutant did indeed label with antibodies directed against Yptlp. Like the sla2 mutants, aggregates of vesicles located at the early bud neck of actl-l cells labeled with the anti-Yptlp antibodies ( Figure 10A ), whereas vesicles located within the early bud did not. At 37°C the actl-l mutant also formed ring-like membrane structures ( Figure 10C ) similar to those occasionally observed in the sla2 deletion mutants incubated at 37°C (see above Figure 4F ). As in the sla2 mutants, the vesicles associated with these ring-like membrane structures labeled with antibodies directed against Yptlp. Vesicles located within the small bud as well as at the septum and bud tips showed little labeling with anti-Sec4p antibodies. The level of anti-Sec4p labeling of secretory vesicles located at areas of cell growth was consistent with that observed in the sla2 mutants and, as in the sla2 mutants, was sparse relative to the antiSec4p labeling observed in wild-type cell sections (our unpublished observations).
These results indicate that the actin cytoskeleton mutants sla2 and actl-l have analogous defects in cell surface growth and accumulate similar secretory vesicles.
The Late Secretory Mutants secl-1, sec6-4, and sec4-8 Accumulate Yptlp-and Sec4p-containing Vesicles
Our biochemical results of sla2 mutants, together with the cell cycle-dependent localization of clustered vesicles at the base of the neck of small budded cells, strongly suggest a secretory defect either in a late
Golgi compartment or in Golgi-to-plasma membrane transport. However, the immunolocalization of Yptlp to vesicles that accumulate in both the sla2 and the actl-l mutant would seem to indicate a defect in intra-Golgi transport. It is possible to postulate that Yptlp, besides acting in ER-to-Golgi and early intraGolgi transport, is associated with later steps in the secretory pathway. If Yptlp were in fact associated with a late step in the secretory pathway, some of the known late-acting secretory mutants m pected to accumulate secretory vesicles the antibodies directed against Yptlp. To tE examined three well-characterized late se tants, secl-1, sec6-4, and sec4-8 Govindan et al., 1995) .
Consistent with previous reports, secl and sec4 -8 cells incubated at their nor temperature (37°C) for 1 h accumulated large secretory vesicles, and this accumulation was polarized into the bud (see Figures 11 and 12) . Interestingly, the sec6-4 and sec4-8 cells incubated at 37°C contained many vesicles that were clustered together in a manner reminiscent of the sla2 and actl-l mutants, suggesting that these mutants accumulate vesicles at a similar step in protein secretion. The secl-1 mutant did not show a similar clustering of vesicles. However, it is possible that specific clustering of vesicles does occur in the secl-1 mutant but that this clustering is obscured by the dense accumulation of vesicles that is characteristic of this *M k.i~^^< mutant.
Immuno-EM experiments demonstrated that the vesicles that accumulated in secl-1, sec6 -4, and sec4-8 were immunoreactive with antibodies directed against Yptlp (Figure 11 , A, C, E, and G; Figure 12, A and B) (Goud et al., 1988) . These results prompted us to apply anti-Sec4p antibodies to the secl-1 and sec6-4 cell sections. Not surprisingly, many of the vesicles that accumulated in these two sec mutants labeled with antibodies directed against Sec4p (Figure 11 ). The strongest localization of Sec4p, in both sec6-4 and secl-1, appeared to be on vesicles accumulated along the plasma membrane, at the septum, at the bud tip, aining vesicles. and within the small bud ( Figure 11 , B, D, F, and H). ptlp (A and B) Further, in the sec6-4 mutant, as in the sla2 and the ubated at 37'C actl-l mutants, the anti-Sec4p antibodies did not label not localize to the clustered vesicles (for an example see Figure 1iF) protein(Goud that, it will be remembered, labeled strongly with Aeless label the anti-Yptlp antibodies.
that the cross-
The affinity-purified anti-Sec4p antibodies used in our studies have been shown to have a greatly reduced affinity for the mutant sec4-8 protein (Goud et al., 1988) . Consistent with that result, we observed ight be ex-no localization of the anti-Sec4p antibodies to the it label with vesicles that accumulated in sec4-8 cells at 37°C est this, we ( Figure 12C ). nonpermissive temperature (Lillie and Brown, 1994) . This result, along with our observation that the actin cytoskeleton mutants sla2 and actl accumulate Yptlppositive vesicles and not Sec4p-positive vesicles, suggests that a defect in the actin cytoskeleton might be the reason for accumulation of Yptlp positive vesicles in late secretory mutants. To see whether this generalization might extend even to sec4 mutants, we examined the actin cytoskeleton organization by rhodamine-phalloidin fluorescence microscopy in a sec4-8 mutant grown at 25°C and incubated at 360C.
After 30 and 60 min at 36°C, the sec4-8 mutant cells exhibited obvious defects in the organization of the actin cytoskeleton ( Figure 13, c-f ). These defects included a depolarized distribution of cortical actin structures, diffuse cytoplasmic staining, loss of brightly stained actin cables, and, occasionally, large brightly staining cortical actin patches. Wild-type controls responded to temperature shift without depolarization of the actin cytoskeleton ( Figure 13, a and b) . The sec4-8 actin cytoskeleton defects appear similar to those previously described by Lillie and Brown (1994) for the secl-1 and sec6-4 mutants.
DISCUSSION
The morphological defects commonly observed in mutants defective in the yeast actin genes and in other genes thought to control actin cytoskeleton organization include perturbation of structures associated with secretory pathways. Ultrastructural studies have shown that many actin cytoskeleton mutants specifically accumulate secretory vesicles and membranes. Previous immunofluorescence light microscopy studies of sla2 mutants revealed the delocalization of cortical actin structures expected of mutations in genes associated with the actin cytoskeleton (Holtzman et al., 1993) . In this study we have shown that sla2 mutants, like actl mutants, have defects in cell wall morphology, accumulate large, 40-to 60-nm, secretory vesides and are defective in the late stages of protein secretion. These phenotypes are entirely consistent with a role for the actin cytoskeleton in protein secretion and wall deposition.
Many, but not all, actin cytoskeleton mutants are also defective in endocytosis (Munn et al., 1995) and actl and sla2(end4) mutants have been shown to be specifically defective in the internalization steps of receptor mediated endocytosis (Kubler and Riezman, 1993; Raths et al., 1993) both antigens. Indeed, our aggregate results regarding location and clustering of vesicles in both mutant and wild-type cells suggests that there might be two kinds of vesicles accumulating in these mutants.
In both the late sec mutants and the actin cytoskeleton mutants, we observed specific clustering of large secretory vesicles. These clustered vesicles were immunoreactive with antibodies directed against Yptlp and not with antibodies directed against Sec4p. Also, we demonstrated that the kinetics of protein transport to and through the Golgi apparatus in the sla2 mutants were similar to that observed in wild-type cells, suggesting that the membrane compartments required for intra-Golgi protein transport are intact. Further, in wild-type cells we could find large Yptlp-associated vesicles usually in clusters near where Golgi might be. These results suggest that the Yptlp-associated vesicles are normal compartments and that the different GTPase-containing vesicles constitute two distinct classes, Yptlp and Sec4p associated.
A straightforward way to interpret these results is to hypothesize that the actin cytoskeleton is functionally involved in a specific step in the latter part of the secretory pathway. A kinetic or absolute defect in this step results in the accumulation of Golgi-derived Yptlp-associated large vesicles. The hypothesized actin cytoskeleton-dependent step would be prior to the Sec4p-associated vesicle step (Figure 14) . A complete consonance with the known facts could be achieved by hypothesizing further that defects in later steps (especially those that result in the accumulation of the classical "late" Sec4p-associated vesicles) result in disorganization of the actin cytoskeleton, which in turn causes a problem at the step in which the cytoskeleton is involved. This idea accounts nicely for the observations that defects in SEC1, SEC6 (Lillie and Brown, 1994) , SEC3 (Haarer et al., 1996) , and now also SEC4 ( Figure 13 ) result in a similar depolarization of actin staining. Why Yptlp should be associated with late secretory vesicles is still unexplained, as previous biochemical and genetic studies have failed to implicate Yptlp function with vesicle transport from the late Golgi to the plasma membrane. It may be that Yptlp is associated with these vesicles in a nonfunctional or nonobligatory way. On the other hand, it may be that the Yptlp-associated vesicles we have identified are intraGolgi transport vesicles that accumulate due to a more general loss of Golgi compartment organization. Under this hypothesis, the actin cytoskeleton would be implicated in maintenance of the integrity of the Golgi compartment(s) in addition to any role in bringing the Golgi and/or derived vesicles to their proper positions within or near growing membrane surfaces.
This interpretation is somewhat difficult to harmonize with our biochemical analysis of protein transport in the sla2 mutants. We found that in the sla2 mutants, CPY, which is transported to the vacuole via a Kex2p-containing late Golgi compartment, is matured with wild-type kinetics. This result would seem to require a functionally intact Golgi in sla2 mutants. One way to rectify this conflict is to postulate that CPY is transported to the vacuole via a late Golgi compartment that is structurally distinct (and thereby actin independent) from the Golgi compartment(s) utilized for secretion of invertase.
Recently, two distinct classes of late secretory vesicles that carry different protein cargoes have been distinguished on the basis of equilibrium density centrifugation (Harsay and Bretscher, 1995) . These vesicles accumulate within and have been purified from extracts of several late-acting secretory mutants, including secl-1 and sec6-4. This observation has lent credence to the idea that at least two late secretory vesicle types emanate from the yeast Golgi compartment(s) following distinct parallel pathways to the plasma membrane. In that same report, Harsay and Bretscher (1995) also reported an accumulation of secretory vesicles in the sla2-41(end4-1) mutant. Importantly, the sla2-41 vesicles were shown to represent exclusively one of the two vesicles classes shown to accumulate in the late Golgi-to-plasma membrane secretory mutants. We also observed two distinct classes of vesicles accumulated in the late sec mutants sec6-4 and secl-1, only one of which accumulated in the sla2 mutants we examined. Thus, it may be that the Yptlpand Sec4p-associated vesicles we identified constitute the same classes of vesicles identified by Harsay and Bretscher (1995) . However, direct correlation of the distinct protein cargoes identified by Harsay and Bretscher (1995) with the specific GTPase-associated vesicles identified in this study will be necessary to unambiguously confirm any relationship(s) between these vesicle classes.
Roles of the Actin Cytoskeleton in Cell Wall Deposition and Protein Secretion Are Separable Lastly, we observed defects in cell wall morphology in the sla2 and actl mutants. These cell wall defects could, at least partially, be the result of an endocytosis defect. It has been speculated that endocytosis might be required to maintain a polarized distribution of cell surface proteins, such as cell wall-synthesizing enzymes. Thus, mutants defective in endocytosis would be expected to have a continuous delocalized deposition of cell wall, resulting in the thick multiwalled morphology observed in the sla2 and actl-l mutants. This would be consistent with the constitutive defect in fluid-phase endocytosis observed in sla2-41 and actl-l mutants (Raths et al., 1993; Kubler and Riezman, 1993) . However, this interpretation is made less attractive because only a minor defect in the cell wall morphology is observed in a sac6 deletion mutant (Mulholland and Botstein, personal observation) that has been shown to be totally and constitutively defective in endocytosis (Kubler and Riezman, 1993) . Thus, although defects in endocytosis may contribute to delocalized wall deposition, it is most likely not the primary cause.
We have also shown that the defects in cell wall morphology observed in the sla2 and actl-l mutants, unlike their secretory defects, are not temperature sensitive. Furthermore, the sla2 and the actl-l mutants initially accumulate vesicles within the bud (as do the late sec mutants) and not in the mother cell where the cell wall defects are observed. Additionally, defects in cell wall morphology were not observed in any of the single sec mutants we examined. In contrast, constitutive cell wall defects were observed in the sec-sla2 double mutants we studied. These sec-sla2 double mutants showed the temperature-independent mothercell wall defect of their sla2 component, and the temperature-dependent secretion defect of their sec component-the epistasis was opposite for the two phenotypes. Together these results suggest that the wall defects observed in the actin cytoskeleton mutants do not result trivially from defects in polarized protein secretion.
Rather, our results suggest that the function of the actin cytoskeleton in cell wall deposition and in protein secretion are separable. It has been proposed that the cortical actin patch has a direct role in cell wall biosynthesis (Mulholland et al., 1994) . In this report we have shown that the sla2 and actl-l mutants have a constitutive temperature-independent defect in cell wall morphology and it has been previously demonstrated that these mutants have a constitutive temperature-independent delocalization of cortical actin patches (Holtzman et al., 1993) . Thus, we speculate that the wall defects observed in these mutants results from the depolarization of the cortical actin cytoskeleton during growth of the mother.
To conclude, our results implicate the actin cytoskeleton in two apparently separable functions. One of these function involves the metabolism of a newly described large post-Golgi secretory vesicle. The other is the previously hypothesized, presumably direct, involvement in cell wall deposition.
